As of 2025-12-17, the Relative Valuation of Collegium Pharmaceutical Inc (COLL) is 46.90 USD. This relative valuation is based on P/E multiples. With the latest stock price at 48.71 USD, the upside of Collegium Pharmaceutical Inc based on Relative Valuation is -3.7%.
The range of the Relative Valuation is 35.17 - 58.29 USD.
| Range | Selected | |
| Trailing P/E multiples | 19.0x - 20.3x | 20.1x |
| Forward P/E multiples | 19.8x - 21.1x | 20.5x |
| Fair Price | 35.17 - 58.29 | 46.90 |
| Upside | -27.8% - 19.7% | -3.7% |
| Date | P/E |
| 2025-12-16 | 26.35 |
| 2025-12-15 | 26.51 |
| 2025-12-12 | 26.30 |
| 2025-12-11 | 26.16 |
| 2025-12-10 | 26.43 |
| 2025-12-09 | 25.44 |
| 2025-12-08 | 25.91 |
| 2025-12-05 | 25.91 |
| 2025-12-04 | 25.65 |
| 2025-12-03 | 25.88 |
| 2025-12-02 | 25.70 |
| 2025-12-01 | 25.35 |
| 2025-11-28 | 25.25 |
| 2025-11-26 | 25.00 |
| 2025-11-25 | 24.66 |
| 2025-11-24 | 24.65 |
| 2025-11-21 | 24.41 |
| 2025-11-20 | 23.77 |
| 2025-11-19 | 24.05 |
| 2025-11-18 | 24.52 |
| 2025-11-17 | 24.52 |
| 2025-11-14 | 24.87 |
| 2025-11-13 | 25.09 |
| 2025-11-12 | 25.61 |
| 2025-11-11 | 24.25 |
| 2025-11-10 | 23.54 |
| 2025-11-07 | 22.88 |
| 2025-11-06 | 21.99 |
| 2025-11-05 | 19.39 |
| 2025-11-04 | 19.34 |
| 2025-11-03 | 19.53 |
| 2025-10-31 | 19.47 |
| 2025-10-30 | 19.28 |
| 2025-10-29 | 18.83 |
| 2025-10-28 | 19.15 |
| 2025-10-27 | 18.83 |
| 2025-10-24 | 19.09 |
| 2025-10-23 | 19.22 |
| 2025-10-22 | 19.31 |
| 2025-10-21 | 19.13 |
| 2025-10-20 | 18.85 |
| 2025-10-17 | 18.36 |
| 2025-10-16 | 17.96 |
| 2025-10-15 | 17.78 |
| 2025-10-14 | 17.40 |
| 2025-10-13 | 17.33 |
| 2025-10-10 | 17.33 |
| 2025-10-09 | 17.96 |
| 2025-10-08 | 17.92 |
| 2025-10-07 | 18.06 |